Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

VRAX

Virax Biolabs Group Ltd

CIK 0001885827 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$3.19
↓ 0.26 (-7.54%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$2.54M
P/E Ratio
-0.42
EPS
-1.62
Dividend Yield
Not covered
52W Position
24%
Beta
2.27

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.47
P/S
401.58
EV/Revenue
-266.39
ROE
-111.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 24%
$0.10$13.19

Latest Financials

2025-03-31 FY
Revenue
$6.33K
Net Income
-$6.07M
Total Assets
$6.43M
Free Cash Flow
-$5.17M

Recent news